Uwe Siebert, Prof., MD, MPH, MSc, ScD
Prof. of Public Health (UMIT), Adjunct Prof. of Health Policy and Management (Harvard Univ.)
UMIT, Dept. Public Health&HTA/ ONCOTYROL, Area 4 HTA&Bioinformatics/ Harvard T.H. Chan School Public Health, Center for Health Decision Science, Dept. Health Policy&Management/ Harvard Medical School, Institute for Technology Assessment&Dept. Radiology
Dept. of Public Health & HTA/ Area 4 HTA & Bioinformatics/ Dept. Health Policy & Management/ Institute for Technology Assessment
Eduard Wallnoefer Center I
Hall in Tyrol/ Innsbruck/ Boston
Austria
6060/ 6020/ 02115
Papers:
CHRONIC MYELOID LEUKEMIA TREATMENT: STARTING WITH A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB?